{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:13:49Z","timestamp":1787004829980,"version":"build-2736575974"},"reference-count":82,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1053\/j.semnuclmed.2006.03.002","type":"journal-article","created":{"date-parts":[[2006,6,8]],"date-time":"2006-06-08T09:19:17Z","timestamp":1149758357000},"page":"194-205","source":"Crossref","is-referenced-by-count":88,"title":["Respective Roles of Thyroglobulin, Radioiodine Imaging, and Positron Emission Tomography in the Assessment of Thyroid Cancer"],"prefix":"10.1053","volume":"36","author":[{"given":"Peter","family":"Lind","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Kohlf\u00fcrst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2006.03.002_bib1","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1089\/105072502761016539","article-title":"Iodine supplementation in Austria","volume":"12","author":"Lind","year":"2002","journal-title":"Thyroid"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib2","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1056\/NEJM198508153130707","article-title":"Nodular thyroid disease. Evaluation and management","volume":"313","author":"Rojewski","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib3","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S0002-9610(05)80728-7","article-title":"Role of ultrasound in the management of thyroid nodules","volume":"164","author":"Watters","year":"1992","journal-title":"Am J Surg"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib4","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0272-2712(18)30434-7","article-title":"Fine needle aspiration cytology of the thyroid","volume":"13","author":"Gharib","year":"1993","journal-title":"Clin Lab Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/thy.1998.8.283","article-title":"Ultrasound-guided fine-needle aspiration biopsy of thyroid masses","volume":"8","author":"Carmeci","year":"1998","journal-title":"Thyroid"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/PL00006664","article-title":"Value of ultrasound-guided fine needle aspiration biopsy of thyroid nodules in an endemic goitre area","volume":"27","author":"Mikosch","year":"2002","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib7","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s002590050450","article-title":"Multi-tracer imaging of thyroid nodules","volume":"26","author":"Lind","year":"1999","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00003072-199106000-00010","article-title":"Tl 201 thyroid imaging in differentiating benign from malignant thyroid nodules","volume":"16","author":"El-Desouki","year":"1991","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib9","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/00006231-199508000-00011","article-title":"Evaluation of thyroid nodules for malignancy using T-99m-sestamibi","volume":"16","author":"Sundran","year":"1995","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib10","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s002590050451","article-title":"The role of Tc-99m methoxy-isobutyl-isonitrile (MIBI) scintigraphy in the differential diagnosis of cold thyroid nodules","volume":"26","author":"Mezosi","year":"1999","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib11","first-page":"62","article-title":"Tc-99m MIBI scintigraphy of thyroid nodules in an endemic goiter area","volume":"38","author":"Kresnik","year":"1997","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib12","first-page":"716","article-title":"Evaluation of thyroid nodules with Tc-99m tetrofosmin dual phase scintigraphy","volume":"24","author":"Kresnik","year":"1997","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib13","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/BF00256624","article-title":"18F-fluorodeoxyglucose imaging in the preoperative diagnosis of thyroid malignancy","volume":"13","author":"Joensuu","year":"1988","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib14","first-page":"728","article-title":"Determination of malignancy of thyroid nodules with positron emission tomography","volume":"114","author":"Bloom","year":"1993","journal-title":"Surgery"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib15","first-page":"453","article-title":"Fluorine-18-fluorodeoxyglucose PET versus thallium-201 scintigraphy evaluation of thyroid tumors","volume":"39","author":"Uematsu","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib16","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.surg.2005.08.031","article-title":"Preoperative evaluation of thyroid nodules with (18)FDG-PET\/CT","volume":"138","author":"Mitchell","year":"2005","journal-title":"Surgery"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib17","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/00006231-199710000-00011","article-title":"An evaluation of FDG PET in the detection and differentiation of thyroid tumors","volume":"18","author":"Sasaki","year":"1997","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib18","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1067\/msy.2003.71","article-title":"Fluorine-18-fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area","volume":"133","author":"Kresnik","year":"2003","journal-title":"Surgery"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib19","first-page":"272","article-title":"Elevated thyroglobulin","volume":"56","author":"Van Herle","year":"1975","journal-title":"J Clin Invest"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2265.1985.tb01098.x","article-title":"Diagnostic value of single serum thyroglobulin determination on and off thyroid supressive therapy in the follow-up of patients with differentiated thyroid cancer","volume":"23","author":"Pacini","year":"1985","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib21","first-page":"1766","article-title":"Can iodine-131 whole body scan be replaced by thyroglobulin measurement in the postsurgical follow up of differentiated thyroid carcinoma?","volume":"31","author":"Ronga","year":"1990","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib22","first-page":"98","article-title":"Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer","volume":"79","author":"Ozata","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib23","first-page":"1121","article-title":"Serum thyroglobulin autoantibodies","volume":"83","author":"Spencer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"suppl 2","key":"10.1053\/j.semnuclmed.2006.03.002_bib24","doi-asserted-by":"crossref","first-page":"S492","DOI":"10.1007\/s00259-002-0847-9","article-title":"Follow up of differentiated thyroid cancer","author":"Pacini","year":"2002","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1089\/thy.2000.10.171","article-title":"Recurrent differentiated thyroid cancer without elevation of thyroglobulin","volume":"10","author":"Westbury","year":"2000","journal-title":"Thyroid"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib26","first-page":"236","article-title":"Thallium-201 uptake with negative I-131 scintigraphy and serum thyroglobulin in metastatic oxyphilic papillary thyroid carcinoma","volume":"39","author":"Harder","year":"1997","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1210\/jcem.85.1.6310","article-title":"Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer?","volume":"85","author":"Cailaux","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib28","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1210\/jcem.87.4.8274","article-title":"Diagnostic 131-iodine whole body scan may be avoided in thyroid cancer patients who have undetectable stimulated thyroglobulin levels after initial treatment","volume":"87","author":"Pacini","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1089\/thy.2005.15.371","article-title":"Recombinant thyrotropin is helpful in the follow up and I-131 therapy of patients wirh thyroid cancer","volume":"15","author":"Kohlfuerst","year":"2005","journal-title":"Thyroid"},{"issue":"suppl","key":"10.1053\/j.semnuclmed.2006.03.002_bib30","first-page":"25","article-title":"Clinical experience with recombinant human thyroid-stimulating hormone (rhTSH)","volume":"22","author":"Pacini","year":"1999","journal-title":"J Endocrinol Invest"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib31","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1210\/jcem.87.7.8702","article-title":"Is the serum thyroglobulin response to recombinant human thyrotropin sufficient, by itsself, to monitor for residual thyroid carcinoma","volume":"87","author":"Robbins","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib32","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1089\/105072502320288438","article-title":"Management of low-risk well differentiated thyroid cancer based only on thyroglobulin measurement after recombinant human thyrotropin","volume":"12","author":"Wartofsky","year":"2002","journal-title":"Thyroid"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00006231-200403000-00005","article-title":"The influence of functional imaging in differentiated thyroid cancer","volume":"25","author":"Menzel","year":"2004","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1530\/eje.0.1500105","article-title":"Follow-up of low risk patients with differentiated thyroid carcinoma","volume":"150","author":"Schlumberger","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib35","doi-asserted-by":"crossref","first-page":"396","DOI":"10.4158\/EP.6.5.396","article-title":"Role of ultrasonography in the diagnosis and management of thyroid cancer","volume":"6","author":"Haber","year":"2000","journal-title":"Endocr Pract"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib36","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1210\/jc.2002-021702","article-title":"A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma","volume":"88","author":"Mazzaferri","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1053\/nm.2000.4600","article-title":"Treating the patient with differentiated thyroid cancer with thyroglobulin-positive, iodine-131 diagnostic scan negative metastases","volume":"30","author":"Fatourechi","year":"2000","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib38","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1210\/jcem.87.4.8338","article-title":"Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?","volume":"87","author":"Mazzaferri","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib39","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/j.semnuclmed.2005.05.003","article-title":"Changing concepts in the management of differentiated thyroid cancer","volume":"35","author":"Intenzo","year":"2005","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib40","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10354-005-0219-8","article-title":"Diagnosis, treatment and follow-up in case of differentiated thyroid cancer","volume":"19\/20","author":"Lind","year":"2005","journal-title":"Wien Med Wschr"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib41","first-page":"861","article-title":"The significance of I-131 scan dose in patients with thyroid cancer: determination of ablation. Concise communication","volume":"22","author":"Waxman","year":"1981","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib42","first-page":"188","article-title":"I-131 whole body scintigraphy in thyroid cancer patients","volume":"43","author":"Lind","year":"1999","journal-title":"Q J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib43","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1002\/1097-0142(19930601)71:11<3767::AID-CNCR2820711146>3.0.CO;2-W","article-title":"The role of Iodine-131 and Thallium-201 imaging and serum thyroglobulin in the management of differentiated thyroid carcinoma","volume":"11","author":"Dadparvar","year":"1993","journal-title":"Cancer"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib44","first-page":"446","article-title":"Thyroglobulin determination, neck ultrasonography and iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma","volume":"37","author":"Franceschi","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib45","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00006231-199305000-00004","article-title":"Comparison of serum thyroglobulin, I-131 and Tl-201 scintigraphy in the postoperative follow up differentiated thyroid cancer","volume":"14","author":"Van-Sorge-Van Boxtel","year":"1992","journal-title":"Nuc Med Commun"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib46","first-page":"1542","article-title":"Role of initial iodine-131 whole-body scan and serum thyroglobulin in differentiated thyroid carcinoma metastases","volume":"39","author":"Filesi","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib47","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/00003072-198911000-00001","article-title":"Value of post-therapy whole-body 131-I imaging in the evaluation of patients with thyroid carcinoma having undergone high-dose 131-I therapy","volume":"14","author":"Spies","year":"1989","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib48","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0001-2998(95)80017-4","article-title":"False positive results of 131-I whole-body scan in patients with thyroid cancer","volume":"25","author":"Sutter","year":"1995","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib49","first-page":"257","article-title":"Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma","volume":"35","author":"Lubin","year":"1994","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib50","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/0360-3016(88)90381-1","article-title":"Papillary and follicular thyroid cancer; impact of treatment in 1578 patients","volume":"14","author":"Simpson","year":"1988","journal-title":"Int J Rad Oncol Biol Phys"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib51","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s002590050223","article-title":"Decreased uptake of therapeutic doses of iodine-131 after 185 MBq iodine-131 diagnostic imaging for thyroid remnants in differentiated thyroid carcinoma","volume":"25","author":"Leger","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib52","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s002590050217","article-title":"Thyroid stunning","volume":"25","author":"Coakly","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib53","first-page":"1488","article-title":"I-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan","volume":"80","author":"Pineda","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib54","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00259-002-1003-2","article-title":"Should high hTg levels in the absence of iodine uptake be treated","volume":"30","author":"Lind","year":"2003","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib55","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00259-005-1929-2","article-title":"Short-term outcome of differentiated thyroid cancer patients receiving a second iodine-131 therapy on the basis of a detectable serum thyroglobulin level after initial treatment","volume":"33","author":"Pace","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib56","first-page":"1473","article-title":"Possible explanations for patients with discordant findings of serum thyroglobulin and 131I whole-body scanning","volume":"46","author":"Ma","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib57","first-page":"910","article-title":"Imaging of metastases of thyroid carcinoma with fluorine-18-fluorodeoxyglucose","volume":"28","author":"Joensuu","year":"1987","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib58","first-page":"115","article-title":"Comparison of different tracers in the follow up of differentiated thyroid carcinoma","volume":"26","author":"Lind","year":"1999","journal-title":"Act Med Austriaca"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib59","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s002590100626","article-title":"FDG PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, \u201cOnko PET III\u201d, 21. July and 19. September 2000","volume":"28","author":"Reske","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib60","first-page":"1468","article-title":"Fluorine-18 FDG and iodine-131 uptake in thyroid cancer","volume":"37","author":"Feine","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib61","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1089\/thy.1997.7.327","article-title":"Comparison of 18FDG-PET with 131-iodine and 99m Tc-sestamibi scintigraphy in differentiated thyroid cancer","volume":"7","author":"Gr\u00fcnwald","year":"1997","journal-title":"Thyroid"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib62","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1563-2571.2003.02046.x","article-title":"F-18-FDG PET in following up thyroid cancer","volume":"30","author":"Lind","year":"2003","journal-title":"Acta Med Austriaca"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib63","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1089\/thy.1999.9.797","article-title":"Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomograpgy","volume":"9","author":"Conti","year":"1999","journal-title":"Thyroid"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib64","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s004230050109","article-title":"Positron emission tomograpgy with F-18-deoxyglucose in patients with differentiated thyroid carcinoma, elevated thyroglobulin levels and negative iodine scans","volume":"383","author":"Altenvoerde","year":"1998","journal-title":"Langenbecks Arch Surg"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib65","first-page":"71","article-title":"Impact of FDG PET on patients with well differentiated thyroid cancer who present with elevated thyroglobulin and negative I-131 scan","volume":"42","author":"Schluetter","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib66","first-page":"1989","article-title":"Influence of thyroid-stimulating hormone levels on uptake of FDG in recurrent and metastatic differentiated thyroid carcinoma","volume":"41","author":"Moog","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib67","first-page":"7","article-title":"Follow up of thyroid cancer patients using rhTSH-preliminary results","volume":"40","author":"Petrich","year":"2001","journal-title":"Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib68","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1097\/00006231-200412000-00004","article-title":"Impact of SPECT and integrated low-dose CT after radioiodine therapy on the management of patients with thyroid carcinoma","volume":"25","author":"Ruf","year":"2004","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib69","series-title":"Thyroid cancer four 2004","article-title":"PET and PET\/CT in the following up of thyroid cancer patients","author":"Lind","year":"2004"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib70","first-page":"1369","article-title":"A combination ofPET\/CT scanner for clinical oncology","volume":"41","author":"Beyer","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib71","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00259-003-1299-6","article-title":"PET\/CT","volume":"30","author":"Sch\u00f6der","year":"2003","journal-title":"Eur J Nucl Med Mol Immaging"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib72","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1055\/s-2005-858197","article-title":"Clinical experience with a commercially available negative oral contrast medium in PET\/CT","volume":"177","author":"Hausegger","year":"2005","journal-title":"Fortschr Roentgenstr"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib73","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1056\/NEJMoa022136","article-title":"Staging of non-small-cell lung-cancer wirth integrated positron emissiontomography and computed tomography","volume":"348","author":"Lardinois","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib74","first-page":"424","article-title":"PET\/CT","volume":"225","author":"Burger","year":"2002","journal-title":"Radiology"},{"issue":"suppl 1","key":"10.1053\/j.semnuclmed.2006.03.002_bib75","first-page":"S5","article-title":"Towards truly integrated hardware fusion with PET\/CT","volume":"44","author":"Beyer","year":"2005","journal-title":"Nucl Med"},{"issue":"suppl 1","key":"10.1053\/j.semnuclmed.2006.03.002_bib76","first-page":"S13","article-title":"Does PET\/CT render software registration obsolete?","volume":"44","author":"Pietrzyk","year":"2005","journal-title":"Nucl Med"},{"issue":"suppl 1","key":"10.1053\/j.semnuclmed.2006.03.002_bib77","first-page":"S18","article-title":"Clinical PET\/CT imaging","volume":"44","author":"Czernin","year":"2005","journal-title":"Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib78","first-page":"297","article-title":"Initial experience in use of fluorine-18-fluorodeoxyglucose positron emission tomographycomputed tomography in thyroid carcinoma patients with elevated thyroglobulin but negative iodine-131 whole body scans","volume":"46","author":"Ong","year":"2005","journal-title":"Singapore Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib79","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/01.mlg.0000154725.00787.00","article-title":"The role of positron emission tomographycomputed tomography in the management of recurrent papillary thyroid carcinoma","volume":"115","author":"Nahas","year":"2005","journal-title":"Laryngoscope"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib80","first-page":"1366","article-title":"Patient- specific dosimetry for I-131 thyroid cancer therapy using I-124 PET and 3-dimensional-internal dosimetry (3D-ID) software","volume":"48","author":"Sgouros","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib81","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1007\/s00330-004-2350-0","article-title":"Value of 124-I-PET\/CT in staging of patients with differentiated thyroid cancer","volume":"14","author":"Freudenberg","year":"2004","journal-title":"Eur Radiol"},{"key":"10.1053\/j.semnuclmed.2006.03.002_bib82","series-title":"Nuclear Medicine in Clinical Diagnosis and Treatment","first-page":"145","article-title":"Differentiated thyroid cancer","author":"Lind","year":"2004"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299806000158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299806000158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T03:47:46Z","timestamp":1555645666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299806000158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":82,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0001299806000158"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2006.03.002","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}